I've heard that ovarian cancer is hard to detect. Can you tell me more about the symptoms and if there are any screenings?

NIH award of $2.25M funds preclinical studies that will advance Targefrin toward clinical trials for pancreatic cancer ...

“Ovarian cancer has been known as the ‘silent killer’ because many women do not experience symptoms until after it is already widespread and considered advanced,” Eloise Chapman-Davis, MD, a ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators. The ...

Eric Boodman focuses on narrative features, exploring the startling ways that science and medicine affect people’s lives. You can reach Eric on Signal at eboodman.88. To Rebecca Stone, the single most ...

Clinical trial updates in cancer care include a remote study in small cell lung cancer and new findings in ovarian, solid tumor, and urothelial cancers. A new remote clinical trial, entitled SUCCEED, ...

The discovery that tumor vasculature has a molecular profile distinct from normal resting vessels identified tumor vasculature as an important new clinical target. Two recent large studies profiling ...

A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the ...

A gynecologic oncologist at the Mayo Clinic who treats patients with ovarian cancer shares the warning signs she looks for in her own body.

A recent study published in Genes & Diseases reveals a novel role of XPR1 in promoting ovarian cancer growth by regulating autophagy and MHC-I expression. The research, conducted by scientists from ...

Early-stage gynecologic cancer is confined to its original site and often treatable; diagnosis, surgery, and new therapies improve outcomes.